TEST 3 - Please ignore - Immediate table release on June 11

By Prn Test Company, PRNE
Friday, June 10, 2011

LONDON, June 11, 2011 -


- Curabitur molestie mauris sed dolor dictum iaculis

- Duis dictum, purus in condimentum tincidunt

Curabitur molestie mauris sed dolor dictum iaculis. href="www.prnewswire.co.uk/">Nulla sed libero felis, id
viverra urna. Duis dictum, purus in condimentum tincidunt, nisl
lacus porta diam, sit amet suscipit libero est sit amet dui. Lorem
ipsum dolor sit amet, consectetur adipiscing elit.

  • Mauris est velit, iaculis scelerisque tempus semper,
    eleifend ac erat.
  • Duis eu mauris ac risus cursus mattis nec ut erat. Donec
    fringilla dapibus pharetra. Etiam vitae mi quis dolor mattis
    adipiscing. Etiam metus arcu, ultrices quis dapibus sed, mollis sit
    amet nulla.
  • Maecenas vitae nisl tortor, eu pretium nibh. Nullam nisl dui,
    vulputate at accumsan nec, volutpat eu urna.
  • Phasellus mi tellus, varius quis adipiscing sed, euismod id
    quam.
  • Praesent quam nisi, feugiat vel accumsan ac, fermentum non
    libero.
  • Nam aliquam mollis nibh eu placerat.

Curabitur molestie
mauris

Mauris est velit, iaculis scelerisque
(in thousands, except per share amounts)

                                      Three Months Ended   Six Months Ended
                                      (unaudited)          (unaudited)
                                      June 30,  June 30,   June 30,  June 30,
                                      2010      2009       2010      2009
    Continuing operations             $'000     $'000      $'000     $'000
    Revenues (see note 4)             221,125    195,192   415,305   324,971
    Cost of revenues (excl.
    amortization)                     (30,323)   (23,628)  (51,865)  (36,417)
    Amortization of purchased
    intangibles                       (14,898)   (15,105)  (29,432)  (20,459)
    Total cost of revenues            (45,221)   (38,733)  (81,297)  (56,876)
    Gross profit                      175,904    156,459   334,008   268,095
    Operating expenses:
    Research and development          (27,741)   (28,781)  (55,523)  (48,791)
    Sales and marketing               (50,557)   (37,110)  (93,457)  (65,870)
    General and administrative        (17,264)   (15,508)  (34,519)  (26,796)
    Other costs
    Post-acquisition restructuring
    costs                                (558)          -     (558)     (846)
    (Loss) profit on foreign exchange  (2,777)      (694)       184   (1,127)
    Total operating expenses          (98,897)   (82,093) (183,873) (143,430)
    Profit from operations             77,007     74,366   150,135   124,665
    Share of loss of associate           (333)       (85)     (671)     (526)
    Interest receivable                 2,178        168     2,985       791
    Interest payable                  (11,372)    (2,757)  (16,169)   (3,261)
    Profit before income taxes         67,480     71,692   136,280   121,669
    Income taxes                      (15,129)   (20,817)  (34,215)  (36,278)
    Net profit                         52,351     50,875   102,065    85,391
    Basic earnings per share           $ 0.22     $ 0.21    $ 0.42    $ 0.36
    Diluted earnings per share         $ 0.21     $ 0.21    $ 0.42    $ 0.36

Curabitur molestie
mauris

Mauris est velit, iaculis scelerisque

                                            Capital
                        Ordinary   Share   redemption  Own   Merger
                        shares   premium   reserve   shares reserve Sub-total
                        $'000    $'000     $'000      $'000  $'000   $'000
    At January 1, 2010    1,333 1,130,767        135  (845)  27,589 1,158,979
    Retained profit           -         -          -      -       -         -
    Other comprehensive
    income                    -         -          -      -       -         -
    Stock compensation        -         -          -      -       -         -
    Share options
    exercised                 6    13,227          -      -       -    13,233
    EBT options
    exercised                 -         -          -     57       -        57
    Equity element of
    convertible loan
    notes                     -    97,815          -      -       -    97,815
    Deferred tax on
    stock options             -         -          -      -       -         -
    At June 30, 2010      1,339 1,241,809        135  (788)  27,589 1,270,084

href="www.google.co.uk/search?hl=en&source=hp&q=prnewswire&aq=0&aqi=g4g-s4g2&aql=&oq=prnews">
Aenean ligula leo, dignissim volutpat lacinia vel, consectetur
in lorem. In dignissim quam nec leo sagittis tincidunt
scelerisque nunc egestas.
Donec lobortis interdum magna id
congue. Phasellus mattis, turpis ut vulputate faucibus, tortor
sapien mollis justo, nec vulputate arcu nibh at dolor. Quisque
tempus, quam sed aliquam interdum, lacus sem elementum justo, nec
dictum quam ante ac orci. Integer ac nisl eget felis aliquet
viverra. Doneclacus enim, fringilla ut elementum in,
hendrerit sed odio.

Contact:
Morbi diam magna
Ultricies quis facilisis et
Sagittis@neque.com

.

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :